Charles S. Fermaintt

448 total citations
12 papers, 327 citations indexed

About

Charles S. Fermaintt is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Charles S. Fermaintt has authored 12 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Organic Chemistry. Recurrent topics in Charles S. Fermaintt's work include interferon and immune responses (6 papers), Glycosylation and Glycoproteins Research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Charles S. Fermaintt is often cited by papers focused on interferon and immune responses (6 papers), Glycosylation and Glycoproteins Research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Charles S. Fermaintt collaborates with scholars based in United States, Spain and South Korea. Charles S. Fermaintt's co-authors include Nan Yan, April L. Risinger, Mark A. Lehrman, Susan L. Mooberry, Herbert C. Morse, John Atkinson, Takuya Miyazaki, Tomomi Sakai, Ningguo Gao and Quan‐Zhen Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Immunity.

In The Last Decade

Charles S. Fermaintt

11 papers receiving 326 citations

Peers

Countries citing papers authored by Charles S. Fermaintt

Since Specialization

Citations

This map shows the geographic impact of Charles S. Fermaintt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Fermaintt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Fermaintt more than expected).

Fields of papers citing papers by Charles S. Fermaintt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles S. Fermaintt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Fermaintt. The network helps show where Charles S. Fermaintt may publish in the future.

Co-authorship network of co-authors of Charles S. Fermaintt

This figure shows the co-authorship network connecting the top 25 collaborators of Charles S. Fermaintt. A scholar is included among the top collaborators of Charles S. Fermaintt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles S. Fermaintt. Charles S. Fermaintt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Malate dehydrogenase as a multi-purpose target for drug discovery 2024 ·Essays in Biochemistry ·Charles S. Fermaintt, (unknown)	5
2	The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models 2022 ·Cancers ·(unknown), Charles S. Fermaintt, (unknown), (unknown), Susan L. Mooberry, April L. Risinger	21
3	Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA 2021 ·Molecular Pharmacology ·Charles S. Fermaintt, (unknown), Huiyun Liang, Susan L. Mooberry, April L. Risinger	25
4	Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential 2021 ·Cancers ·Charles S. Fermaintt, (unknown), Shengxin Cai, (unknown), (unknown), (unknown), Barry R. O’Keefe, Susan L. Mooberry, Robert H. Cichewicz, April L. Risinger	15
5	Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site 2021 ·Proceedings of the National Academy of Sciences ·Susan Matthew, Qi-Yin Chen, Ranjala Ratnayake, Charles S. Fermaintt, Daniel Lucena‐Agell, (unknown), A.E. Prota, (unknown), Xiaomeng Wang, J. Fernando Dı́az, April L. Risinger, Valerie J. Paul, María A. Oliva, Hendrik Luesch	62
6	Abstract P5-05-03: Eribulin treatment activates type 1 IFNs to promote a gene expression signature associated with antitumor immunity 2020 ·Cancer Research ·Charles S. Fermaintt, (unknown), Susan L. Mooberry, April L. Risinger	0
7	A bioactive mammalian disaccharide associated with autoimmunity activates STING-TBK1-dependent immune response 2019 ·Nature Communications ·Charles S. Fermaintt, (unknown), Zhida Liu, Nozomi Ishii, Junichi Seino, Nicole Dobbs, Tadashi Suzuki, Yang‐Xin Fu, Mark A. Lehrman, Ichiro Matsuo, Nan Yan	19
8	Mammalian STT3A/B oligosaccharyltransferases segregate N-glycosylation at the translocon from lipid-linked oligosaccharide hydrolysis 2018 ·Proceedings of the National Academy of Sciences ·Hua Lu, Charles S. Fermaintt, Н. А. Черепанова, Reid Gilmore, Nan Yan, Mark A. Lehrman	29
9	DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice 2017 ·Journal of Autoimmunity ·Tomomi Sakai, Takuya Miyazaki, Dong-Mi Shin, Yong‐Soo Kim, Chen‐Feng Qi, Robert N. Fariss, Jeeva Munasinghe, Hongsheng Wang, Alexander L. Kovalchuk, Parul H. Kothari, Charles S. Fermaintt, John Atkinson, Fred W. Perrino, Nan Yan, Herbert C. Morse	30
10	Mitotic Phosphorylation of TREX1 C Terminus Disrupts TREX1 Regulation of the Oligosaccharyltransferase Complex 2017 ·Cell Reports ·Martin Kucej, Charles S. Fermaintt, Kun Yang, Ricardo A. Irizarry-Caro, Nan Yan	20
11	Cellular metabolism of unnatural sialic acid precursors 2015 ·Glycoconjugate Journal ·(unknown), Charles S. Fermaintt, (unknown), Janet E. McCombs, Nicole Nischan, Jennifer J. Kohler	22
12	Cytosolic Nuclease TREX1 Regulates Oligosaccharyltransferase Activity Independent of Nuclease Activity to Suppress Immune Activation 2015 ·Immunity ·Maroof Hasan, Charles S. Fermaintt, Ningguo Gao, Tomomi Sakai, Takuya Miyazaki, Sixin Jiang, Quan‐Zhen Li, John Atkinson, Herbert C. Morse, Mark A. Lehrman, Nan Yan	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact